Skip to main content
. 2022 May 30;8(6):342. doi: 10.3390/gels8060342

Figure 13.

Figure 13

The plasma drug concentration–time profile of darunavir after administration by nasal (optimized in situ gel, 30 µL, 2.4 mg/kg) and intravenous (solution, 0.4 mL, 2.4 mg/kg) routes in rats. The data presented are the average of six animals at every time point.